Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07192809

The Effect of Attention Distraction on the Adherence to Exercise, in Chronic Low Back Pain Patients.

This randomized controlled trial aims to investigate whether the use of an attention distraction application during exercise increases patient adherence to exercise programs in chronic non-specific low back pain (CNSLBP). In addition, the study will examine whether higher adherence to exercise leads to improved outcomes in pain levels, functional capacity, kinesiophobia, quality of life, central sensitization, and pain catastrophizing.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Thessaly

Lamia, Central Greece, 35132, Greece

About this study

Participants will be stratified based on their level of physical activity according to the International Physical Activity Questionnaire (IPAQ) into:

  • Low physical activity
  • Moderate physical activity
  • High physical activity

They will then be randomly assigned to one of two groups: (1) an experimental group using the attention distraction application during the standard exercise program and (2) a control group following the same standard exercise program without distraction. The intervention will last for 8 weeks, with participants attending three non-supervised sessions per week (total: 24 training sessions). Each session will last approximately 25-30 minutes. Adherence to the exercise program will be monitored through the EARS questionnaire and the distraction application (The total score ranges from 0 to 24, where a higher score reflects better adherence).

The intervention group sessions consist of 5 minute submaximal warm-up followed by 25 minutes of stabilisation and resistance training with exercises focused on strength and stabilisation while using the distraction application. The training will consist of two parts: warming-up and the resistance and stabilisation program. The resistance program will consist of 4 exercises: knee flexion, abdominal crunches, prone superman and leg extension. Each exercise will be performed for 3 sets of 10 repetitions with a rest of 30 sec corresponding to every set , and 1 minute between each exercise. The stabilisation program will consist of 3 exercises: bridge, plank and side plank. Each exercise will be performed for 3 sets of 1 repetition (maximum time) with a rest of 30 sec corresponding to every set and 1 minute between each exercise. Four levels of difficulty will be given for each exercise to allow for progression. Every 2 weeks, there will be a progression that will be achieved by increasing the resistance band tension, by changing the base of support or my modifying the length of resistance level arm.

In the control group they will perform the same exercises without the distraction-based application.

The exercise intensity will be monitored by the researcher, as determined by the patient's ability to complete three sets of 8-12 repetitions for a given exercise and a CR10scale. The progression will be in line with guidelines provided by the American College of Sports Medicine.

Adherence to the program for both groups will be assessed by the Exercise Adherence Rating Scale (EARS - GR).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years
  • Chronic non-specific low back pain (≥3 months)
  • No physical therapy or structured exercise program in the last 3 months
  • Willingness to use the attention distraction application (for the AD-APP group)
  • Completion of the International Physical Activity Questionnaire (IPAQ)

Exclusion criteria

  • History of spinal surgery
  • Neurological conditions affecting movement
  • Regular use of pain relief medication within the past two weeks
  • Pregnancy
  • Severe psychological disorders that may affect compliance

Treatment and study plan

Stabilisation exercise, resistance exercise and distraction task

Other

The 8-week exercise intervention consists of 25 minutes non supervised training while distracting their attention with a knowledge based application

stabilisation exercise and resistance exercises

Other

The 8-week exercise intervention consists of 25 minutes non supervised training without distracting their attention with a knowledge based application

Primary outcomes

  1. Adherence to exercise

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Exercise Adherence Rating Scale in Greek (EARS-GR).

    The Exercise Adherence Rating Scale (EARS) is a questionnaire used to assess how well individuals adhere to prescribed exercise programs. It utilizes a 5-point Likert scale for each item, with higher scores indicating better adherence. The total score ranges from 0 to 24, with higher scores representing greater adherence.

  2. Adherence to exercise

    Time frame: During the 6 month intervention period.

    Measured through app recorded metrics, including number of sessions (number)

  3. Adherence to exercise

    Time frame: During the 6 month intervention period.

    Measured through app recorded metrics, including duration per session (minutes)

  4. Adherence to exercise

    Time frame: During the 6 month intervention period

    Measured through app recorded metrics including frequency of use per week (minutes)

  5. Adherence to exercise

    Time frame: During the 6 month intervention period

    Measured through app recorded metrics, including number of questions answered

  6. Adherence to exercise

    Time frame: During the 6 month intervention period

    Measured through app recorded metrics, including total active time (minutes).

Secondary outcomes

  1. Pain Intensity

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Numeric Pain Rating Scale (NPRS).

    The Numeric Pain Rating Scale (NPRS) is a widely used tool for assessing pain intensity, typically ranging from 0 to 10. In this scale, 0 represents no pain, and 10 represents the worst pain imaginable. Patients are asked to verbally select a number that best reflects their pain level.

  2. Anxiety, Stress, and Depression

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Depression, Anxiety, and Stress Scale (DASS-21).

    The Depression Anxiety Stress Scales 21 (DASS-21) is scored by summing the responses to each of the three subscales: Depression, Anxiety, and Stress. Each subscale contains 7 items, and each item is scored on a scale of 0 to 3. The raw scores for each subscale are then multiplied by 2 to get the final score for each domain, which can range from 0 to 42.

  3. Functionality

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Oswestry Disability Index (ODI).

    The Oswestry Disability Index (ODI) is scored out of a total of 50 points, with each of the 10 sections having a maximum score of 5. To calculate the ODI score, sum the scores for each section, divide by the total possible score (50), and multiply by 100 to express it as a percentage.

  4. Pain Catastrophizing

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Pain Catastrophizing Scale (PCS).

    The Pain Catastrophizing Scale (PCS) is a 13-item questionnaire used to assess pain catastrophizing, with higher scores indicating greater levels of catastrophizing. Scores range from 0 to 52, and a score above 30 is considered clinically significant. The PCS also has three subscales: rumination, magnification, and helplessness.

  5. Central Sensitization

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Central Sensitization Inventory (CSI).

    The CSI, or Central Sensitization Inventory, is a questionnaire used to assess the severity of Central Sensitization Syndrome (CSS). It consists of 25 questions (Part A) scored on a 5-point Likert scale, with higher scores indicating more severe symptoms. Part B is not used for scoring but provides additional clinical information. The total score ranges from 0 to 100, with different ranges corresponding to different severity levels: subclinical (0-29), mild (30-39), moderate (40-49), severe (50-59), and extreme (60-100).

  6. Kinesiophobia

    Time frame: Baseline, Week 8, and follow-up (6 months)

    Tampa Scale of Kinesiophobia (TSK).

    The Tampa Scale for Kinesiophobia (TSK) is a questionnaire used to assess fear of movement or re-injury, often related to chronic pain conditions. Scoring involves summing the responses to each item, with higher scores indicating greater kinesiophobia. The original TSK has 17 items, while a shorter version, TSK-11, has 11 items. The TSK-11 is more commonly used due to its reduced administration time and similar psychometric properties.

  7. Individual's health-related quality of life

    Time frame: Baseline, Week 8, and follow-up (6 months)

    12-Item Short Form Survey (SF-12)

    The SF-12v2 scoring provides a Physical Component Summary (PCS) and a Mental Component Summary (MCS) score, both with a mean of 50 and a standard deviation of 10 in the US general population. Higher scores indicate better health on both scales. These scores are derived from the 12 individual items, which are scored and then transformed using regression weights to generate the PCS and MCS scores.

  8. Effect of Physical Activity Level

    Time frame: Analyzed post-intervention based on IPAQ stratification

    International Physical Activity Questionnaire (IPAQ).The patients will be categorized based on their level of physical activity, and accordingly, they will be assigned different exercise programs. Depending on their activity level, patients will perform exercises with a corresponding number of repetitions, weekly frequency, and intensity.

    The International Physical Activity Questionnaire (IPAQ) scoring involves calculating Metabolic Equivalent of Task (MET) minutes per week to assess physical activity levels. The IPAQ scoring protocol provides guidelines for data processing and analysis, including recommendations for data cleaning. There are two main ways to express the results: as a continuous variable (MET-minutes per week) or categorized into low, moderate, or high activity levels. Investigate whether baseline physical activity level influences outcomes

  9. Work Productivity

    Time frame: Baseline, Week 8, and follow-up (6 months)

    Work Productivity and Activity Impairment Questionnaire - General Health (WPAI-GH Greek).

    The Work Productivity and Activity Impairment Questionnaire - General Health (WPAI:GH) is a tool used to assess the impact of general health problems on work and daily activities over the past seven days. It consists of six questions that evaluate employment status, hours missed from work due to health problems, hours missed for other reasons, hours actually worked, and the degree to which health problems affected productivity while working and during regular daily activities. The last two questions are scored on a scale of 0 to 10, with 0 indicating no effect and 10 indicating complete impairment.

  10. Lumbar Mobility

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Modified-Modified Schober Test.

    The modified-modified Schober test (MMST) is a clinical assessment used to measure lumbar flexion range of motion. It involves marking two points on the back and measuring the distance between them while the patient bends forward, helping to quantify and track lumbar spine flexibility.

  11. Muscle Endurance

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Modified Biering-Sorensen Test.

    It shows that maintaining the Biering-Sorenson position for less than 176 seconds, predicts low back pain within the next year and greater than 198 seconds predicts absence of low back pain. It also reported that Biering-Sorenson test does not have a ceiling effect.

  12. Gait Analysis

    Time frame: Baseline, Week 8, and follow-up (6 months).

    Kinovea software for gait assessment.

    The following parameter will be assessed using Kinovea software: step length (cm).

  13. Gait Analysis

    Time frame: Baseline, week 8 and follow - up (6 months)

    Kinovea software for gait assessment. The following parameter will be assessed using Kinovea software: stride length (cm).

  14. Gait Analysis

    Time frame: Baseline, Week 8 and follow-up (6 months).

    Kinovea software for gait assessment. The following parameter will be assessed using Kinovea software: knee range of motion (degrees).

  15. Gait analysis

    Time frame: Baseline, week 8 and follow-up (6 months)

    Kinovea software for gait assessment. The following parameter will be assessed using Kinovea software: ankle angle (degrees).

  16. Gait analysis

    Time frame: Baseline, week 8 and follow-up (6 months)

    Kinovea software for gait assessment. The following parameter will be assessed using Kinovea software: knee angle (degrees).

  17. Gait analysis

    Time frame: Baseline, Week 8 and follow- up (6 months)

    Kinovea software for gait assessment. The following parameter will be assessed using Kinovea software: pelvic tilt (degrees).

  18. Gait analysis

    Time frame: Baseline, Week 8 and follow-up (6 months)

    Kinovea software for gait assessment. The following parameter will be assessed using Kinovea software: base of support (cm).

Study contacts

Contact information is provided by the study sponsor or research team.

Kyriakos Martinos Petropoulakos, Msc

CONTACT

[email protected]

+41767836957

Savvas Spanos, Phd

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University of Thessaly

Other

Registry information

Official study title

Chronic Non-Specific Low Back Pain: Investigating the Effectiveness of a Dual-Task Program as an Attention Distraction Strategy

Acronym: PAINLESS

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 25, 2025
Registry last updated
Sep 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.